Business question from Julie Morgan (Labour) in the House of Commons on Thursday, 26 April 2001. It occurred during Business statement on President of the Council;Leader of the House of Commons.
President of the Council;Leader of the House of Commons
Supplementary business question on NICE decision on use of beta interferon for multiple sclerosis sufferers.
Secondary information
- Type
- Proceeding contribution
- Reference
- 367 c452
- Session
- 2000-01
- Chamber / Committee
- House of Commons chamber
- Subjects
- Drugs Multiple sclerosis National Institute for Clinical Excellence Abuse Advertising Economic policy Peers Social security benefits
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2026-09-30 15:17:39 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_691546/-question
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_691546/-question
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_691546/-question